Although this study found cancer‐associated CD45+ EPC‐mediated maturity disorders of mFbs in the thymus, the number of CD45+ EPCs is still an unfavourable prognostic factor in patients with cancer [40, 41]. This evidence concerns the gene PTPRC and cancer.